Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Busulfan vs TBI Conditioning for Children with ALL
NCT00002961Phase 3Terminated
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Oct 1995
- Primary completion
- Feb 2001
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of busulfan in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Children's Hospital of Philadelphia. Primary endpoint: Efficacy of conditioning regimen. Started Oct 1995; status: terminated.
02
Drugs
busulfan
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00002961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002961.